The Medical Internal Radiation Dose (MIRD) committee has released its 37th report in 2021, providing updated guidelines and recommendations for calculating internal radiation doses from radiopharmaceuticals. This paper provides an overview of the key updates and implications of MIRD 37 2021, highlighting changes in dose calculation methodologies, new radiopharmaceuticals, and emerging areas of research.
This public link is valid for 7 days and shares a thread, including any personal information you added. This link or copies made by others cannot be deleted. If you share with third parties, their policies apply. Can’t copy the link right now. Try again later. Mendeley | Homepage
Leveraging quantitative SPECT/CT and PET/CT to refine dosage estimates. Key Advancements in MIRD Pamphlet 24 (2021) mird237 2021
If you were looking for a review of a specific technical product with a similar name, please double-check the model number. Common 2021 tech reviews often cover similarly named items like: Xiaomi Mi Notebook Ultra (2021):
In the rapidly advancing field of targeted radionuclide therapy (TRT), accurate dose assessment is critical to ensuring efficacy while minimizing toxicity. The Medical Internal Radiation Dose (MIRD) Committee, a working group of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), has historically provided the gold-standard framework for calculating radiation doses to tissues and organs. In 2021, the committee published , a landmark document that redefines radiation dosimetry principles, particularly in the context of personalized medicine and therapeutic applications. The Medical Internal Radiation Dose (MIRD) committee has
This typically serves as a specific entry, version, or case number within a larger series.
Fragmented; internal departments used custom, isolated data formats. This link or copies made by others cannot be deleted
Patient-Specific Dosimetry in Radioligand Therapy (RLT) for ... - PMC